
Injectsense: Ultra-miniature sensor provider for disease tracking and therapy management.
Founded with a mission to revolutionize disease tracking and therapy management, Injectsense provides ultra-miniature sensors that offer continuous, clinically actionable information. Their core product is an injectable sensor that integrates with a secure digital health platform, enabling real-time monitoring of progressive disease indicators. This technology aims to improve patient outcomes by ensuring that critical health data is always available to healthcare providers, regardless of the patient's location.
Injectsense is supported by a team of engineers and scientists specializing in semiconductor and medical systems industries. The company has garnered attention for its innovative approach to digital health, attracting notable investors and advisors from the healthcare and technology sectors. Their key achievements include the successful development and deployment of their implantable sensors, which have shown significant potential in enhancing disease management and patient care.

Common Sensing
common-sensing.com

Senseer Health
senseer.us

Arborsense
arborsenseinc.com

Dynosense
dynosense.com

Infusense
infusense.com

Zense
zense-life.com

Pocket Clinic
pocketclinic.life

Sensifree
MediSens
medisens.com

Qura
qura.biz

Integrated Medical Sensors

Proteus Digital Health

ivWatch
ivwatch.com

Senseonics Holdings
senseonics.com

Enable Injections
Companies similar to Injectsense include Common Sensing, Senseer Health, Arborsense and Dynosense.
Injectsense was founded in 2014.
Injectsense's headquarters is located in Emeryville, CA, US.
Injectsense's most recent funding round was for $2.5M (USD) in November 2023.
As of Nov 15, 2023, Injectsense has disclosed funding of $17.4M (USD). Undisclosed round amounts are excluded.
Injectsense has 35 employees as of Feb 5, 2024.